Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
JUUL Ends Advertising In U.S. Amid Increasing Concerns Over Health Effects And Teen Use September 26, 2019 Irvin Jackson Add Your Comments Facing growing allegations that children were specifically targeted with advertisements for its addictive e-cigarettes, JUUL Labs has announced that it will suspend all broadcast, print and digital marketing in the United States. The manufacturer announced its plans in a press release issued on September 25, which also indicates that CEO Kevin Burns is stepping down, and will be replaced by a former tobacco executive from Altria. The move comes amid an ongoing criminal probe into prior advertising, the threat of a pending ban on all flavored e-cigarette products, a growing number of JUUL addiction lawsuits and rising concerns that side effects of vaping may cause severe respiratory illnesses. LEARN MORE ABOUT VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About VAPE PEN AND E-CIG LAWSUITS Serious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the press release, JUUL Labs is “suspending all broadcast, print and digital product advertising in the U.S.” The company has also vowed not to fight recently announced plans by federal regulators to ban all flavored e-cigarettes nationwide. The announcement came on the same day FDA Acting Commissioner Ned Sharpless testified before Congress on the growing concerns over vaping, and use of JUUL e-cigarettes specifically. In the testimony, Sharpless indicated the agency is moving aggressively to remove any product which appears to appeal to children from the market. JUUL products are the primary choice of underage vapers. “Most recently, we issued a warning letter to JUUL Labs Inc. for marketing unauthorized modified risk tobacco products, including in a presentation to children given at a school,” Sharpless testified. “Despite these significant efforts, the 2019 NYTS preliminary data, as well as another study supported by NIDA, demonstrate a continued rise in the disturbing rates of youth e-cigarette use, especially through the use of non-tobacco flavors.” Teen Use, Illnesses Leading To More Bans According to preliminary findings of the recent federal survey, more than a quarter of all high school students have vaped this year. In response to the epidemic-levels of use among the nation’s youth, a number of state and federal officials have also announced new plans to ban certain flavored vaping products. Bans have been announced in Michigan, New York and California, and federal regulators say a national flavored e-cigarette ban is in the works. In addition, this week Massachusetts Governor Charlie Baker declared a public health emergency and put in place a four-month ban on vaping products state-wide. Unlike the proposed bans in other states, this affects all vaping products and devices, though it is allegedly only temporary. The bans come as state and federal health experts struggle to understand an outbreak of vaping respiratory illnesses which have affected more than 500 people in 38 states, and have resulted in at least nine deaths. Governor Baker said 61 vaping-related illnesses have occurred in Massachusetts, but the CDC has only confirmed three cases and indicates it is looking at two additional likely cases of what has become known as vaping pulmonary disease. Altria Exec To Become New JUUL CEO In addition to all the other concerns surrounding JUUL, the change in leadership is likely to raise additional warning flags. When Altria first bought 35% of JUUL last year, many, including some lawmakers, raised concerns about the tobacco company’s past actions to marketing cigarettes toward children, and how that behavior may affect JUUL. A number of Senators raised those concerns in a letter to outgoing CEO Burns in April, calling on JUUL to take immediate action to curb teen vaping. However, when Altria made the investment, it issued a press release in which claimed it would allow JUUL Labs to keep its independence. “JUUL will remain fully independent and will have access to Altria’s best-in-class infrastructure and services,” Altria’s statement claimed. The new incoming CEO, K.C. Crosthwaite, was Altria’s Chief Growth Officer, in charge of its efforts to find alternative products to traditional cigarettes. He has been an “observer” on JUUL’s board of directors since Altria’s investment in the company. The move appears to complete the takeover of JUUL by Altria, and seems to confirm a number of fears by lawmakers and others that Altria’s investment would mutate into a takeover of the leading e-cigarette company, ending the vaping industry’s alleged and often touted independence from the traditional tobacco industry. In recent years, critics say JUUL has followed the marketing strategy employed by the tobacco industry decades ago, which has resulted in a new generation of teens addicted to JUULing. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Altria, Children, Electronic Cigarettes, Juul, Respiratory, Tobacco, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: today) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: yesterday) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025) Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 2 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: today) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: yesterday) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 2 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)